Aeris Biosciences Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.9M

  • Investors
  • 10

Aeris Biosciences General Information

Description

Operator of biomaterials intended to promote regenerative cell integration while preventing biofilm formation. The company offers porous materials with micro- and nanoscale hierarchical architectures that actively organize biological interactions, enabling medical device and regenerative medicine applications to support tissue integration and reduce infection risk.

Contact Information

Website
www.aerisbio.com
Formerly Known As
Auxilium Health
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 10000 Cedar Avenue
  • Cleveland, OH 44106
  • United States
+1 (330)
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 10000 Cedar Avenue
  • Cleveland, OH 44106
  • United States
+1 (330)

Aeris Biosciences Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aeris Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Seed Round 14-Jul-2026 $4.9M Completed Startup
8. Accelerator/Incubator 29-Sep-2025 Completed Startup
7. Grant 09-Apr-2025 Completed Startup
6. Grant 24-Apr-2024 Completed Startup
5. Accelerator/Incubator 01-Jan-2024 Completed Startup
4. Accelerator/Incubator 12-Jan-2023 Completed Startup
3. Angel (individual) 14-Dec-2022 Completed Startup
2. Grant 14-Nov-2022 $2.5K $50K Completed Startup
1. Accelerator/Incubator $50K $50K Completed Startup
To view Aeris Biosciences’s complete valuation and funding history, request access »

Aeris Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Aeris Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Aeris Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aeris Biosciences Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Impact Assets Impact Investing Minority
Pointe Angels Angel Group Minority
Bounce Innovation Hub Accelerator/Incubator
US National Science Foundation Accelerator/Incubator
Ohio Department of Development Government
You’re viewing 5 of 10 investors. Get the full list »

Ready to get started?

Request a free trial

Aeris Biosciences FAQs

  • When was Aeris Biosciences founded?

    Aeris Biosciences was founded in 2022.

  • Where is Aeris Biosciences headquartered?

    Aeris Biosciences is headquartered in Cleveland, OH.

  • What is the size of Aeris Biosciences?

    Aeris Biosciences has 10 total employees.

  • What industry is Aeris Biosciences in?

    Aeris Biosciences’s primary industry is Biotechnology.

  • Is Aeris Biosciences a private or public company?

    Aeris Biosciences is a Private company.

  • What is the current valuation of Aeris Biosciences?

    The current valuation of Aeris Biosciences is .

  • What is Aeris Biosciences’s current revenue?

    The current revenue for Aeris Biosciences is .

  • How much funding has Aeris Biosciences raised over time?

    Aeris Biosciences has raised $5.05M.

  • Who are Aeris Biosciences’s investors?

    Impact Assets, Pointe Angels, Bounce Innovation Hub, US National Science Foundation, and Ohio Department of Development are 5 of 10 investors who have invested in Aeris Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process